Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Google X Staff Meet With FDA Pointing Toward New Device
Bloomberg
Friday, January 10, 2014 - 10:59am
tags:
Google X, FDA, devices
PET Imaging Market Poised To Grow With New Compounds
Forbes
Friday, January 10, 2014 - 10:57am
tags:
PET imaging, devices, Fluoropharma
Why Rexahn Pharmaceuticals (RNN) Is Up Today
TheStreet.com
Friday, January 10, 2014 - 10:56am
tags:
Rexahn, Archexin, Supinoxin, RX-3117
Inspire Medical's sleep apnea implant scores for majority in study
Fierce Medical Devices
Friday, January 10, 2014 - 10:36am
tags:
devices, Inspire Medical, sleep apnea, nerve stimulation jaw implant
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Friday, January 10, 2014 - 10:34am
tags:
Ampio, Avanir, Chelsea Therapeutics, Endo Health Solutions, Optina, Northera, Synergy Pharmaceuticals, plecanatide, AVP-825, vintafolide
NuVasive Riding A New Wave Of Optimism
Seeking Alpha
Friday, January 10, 2014 - 10:20am
tags:
NuVasive, devices
Long-term efficacy of Chelsea drug may pose problems for FDA
Yahoo/Reuters
Friday, January 10, 2014 - 10:07am
tags:
Chelsea Therapeutics, FDA, Northera, Droxidopa, neurogenic orthostatic hypotension
Don't Underestimate Amgen: Part 1
Seeking Alpha
Friday, January 10, 2014 - 8:37am
tags:
Amgen, Celgene, Gilead Sciences, Biogen Idec
China pulls J&J trademark on OneTouch diabetes products
Fierce Pharma
Friday, January 10, 2014 - 8:36am
tags:
diabetes, China, JNJ, OneTouch, trademark
Zymeworks pockets $15M, woos Lilly with its double-barreled antibodies
Fierce Biotech
Friday, January 10, 2014 - 8:33am
tags:
Zymeworks, oncology, Eli Lilly, Canada, antibodies
Shire extends ViroPharma tender offer until Jan 23
Reuters
Friday, January 10, 2014 - 8:29am
tags:
ViroPharma, M&A, Shire
Marijuana Stocks: Is This the Pump Before the Dump?
Wall St Cheat Sheet
Friday, January 10, 2014 - 8:27am
tags:
marijuana, cannabis, Cannabis Science, Medical Marijuana, Inc.
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Friday, January 10, 2014 - 8:25am
tags:
M&A, biotech, generics, Merck, Bristol-Myers Squibb, General Electric, Gilead Sciences, Thermo Fisher, Forest Labs, FDA, Acorda Therapeutics, Pfizer, JNJ, Roche, Pharmacyclics
Aegerion gets DOJ subpeona over marketing of cholesterol drug Juxtapid
Yahoo/Reuters
Friday, January 10, 2014 - 8:23am
tags:
DOJ, Juxtapid, Aegerion
Aegerion expects to initiate pediatric study of lomitapide in 2014
Yahoo/Fly on the Wall
Friday, January 10, 2014 - 8:22am
tags:
Aegerion, lomitapide, pediatrics, familial hypercholesterolemia
Intercept stock triples on liver disease study
Yahoo/AP
Friday, January 10, 2014 - 8:20am
tags:
Intercept Pharma, liver disease, obeticholic acid
2014 Biotechnology Catalysts
Seeking Alpha
Friday, January 10, 2014 - 8:14am
tags:
Chelsea Therapeutics, Durect Corporation, EXACT Sciences, Vanda, Pozen, Progenics, MannKind, FDA
Merck Gets FDA Approval For New Formulation Of Isentress
Seeking Alpha
Thursday, January 9, 2014 - 7:02pm
tags:
Isentress, Merck, FDA, HIV
CareFusion to pay $40.1M in false claims case
Yahoo/AP
Thursday, January 9, 2014 - 6:56pm
tags:
False Claims Act, CareFusion, kickbacks
Swiss biotech firm starts new Alzheimer vaccine trial
Reuters
Thursday, January 9, 2014 - 12:30pm
tags:
vaccines, Switzerland, Alzheimer's disease, AC Immune, ACI-35

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.